Showing results (511-520 of 548) with videos related to

Sort By:
Pageof 55
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 2019
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines AgencyAndrew S Levey, Ron T Gansevoort, Josef Coresh, et al.
Circulation|April 13, 2011
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trialAndrew G Bostom, Myra A Carpenter, John W Kusek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 27, 2024
Glomerular Filtration Rate Estimation Using β<sub>2</sub>-Microglobulin and β-Trace Protein in Adults With Solid Tumors: A Prospective Cross-Sectional StudyVerônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
Clinical Chemistry|January 17, 2019
Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MSTiffany A Freed, Josef Coresh, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 8, 2016
Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) StudyMeredith C Foster, Josef Coresh, Chi-Yuan Hsu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collectionLi Fan, Dominik Steubl, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 4, 2020
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique StudyAndrea Matus González, Talia Gutman, Pamela Lopez-Vargas, et al.
Diabetes, Obesity & Metabolism|January 24, 2019
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney diseaseDavid M Charytan, Scott D Solomon, Peter Ivanovich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2016
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKDXun Liu, Meredith C Foster, Hocine Tighiouart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 9, 2009
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.
Pageof 55